Search details
1.
Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA.
Drug Resist Updat
; 65: 100883, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36202008
2.
Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection.
Ann Surg Oncol
; 2022 Jan 04.
Article
in English
| MEDLINE | ID: mdl-35254582
3.
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma.
Gastric Cancer
; 25(6): 1017-1030, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35904677
4.
Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study.
Invest New Drugs
; 39(3): 836-845, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33411209
5.
Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer.
Ther Adv Med Oncol
; 16: 17588359231220600, 2024.
Article
in English
| MEDLINE | ID: mdl-38205077
6.
The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort Analysis.
Biomolecules
; 11(9)2021 08 25.
Article
in English
| MEDLINE | ID: mdl-34572480
7.
Baicalin reversal of DNA hypermethylation-associated Klotho suppression ameliorates renal injury in type 1 diabetic mouse model.
Cell Cycle
; 19(23): 3329-3347, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33190590
Results
1 -
7
de 7
1
Next >
>>